Histologic grade is a better predictor of specific survival than Ki67 in localized ER+/HER2-breast cancer: a real-world study

被引：0
|
作者：
Sanchez, Cesar
Alejandro, Cataldo
Walbaum, Benjamin
Acevedo, Francisco
Constabel, Christine
Saure, Antoine
Rey, Pablo
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-18-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-18-02
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The role of adjuvant endocrine treatment in ER+, PR-, HER2-early breast cancer: a retrospective study of real-world data
    Zhong, Miaochun
    Ren, Xiaoqiu
    Xia, Wenjie
    Qian, Yangyang
    Sun, Kewang
    Wu, Jun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [22] Comparison of ER, PR, Ki67 and HER-2/neu Reactivity Pattern with Patients' Age, Histologic Grade, Tumor Size and Lymph Node Status in Invasive Ductal Breast Cancer
    Ahadi, Mahsa
    Heibatollahi, Motahareh
    Zahedifard, Sara
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2020, 13 (06) : 1 - 5
  • [23] A retrospective study of immunohistochemical detection of Ki67 and correlation with ER, PR, and HER2-neu status in invasive breast cancer
    Prakash, Deepa Meda
    Shivakumar, Swarna
    Bapsy, P. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Ki67 assessment in ER positive / HER2 negative breast cancer: A comparative study between different scoring methods
    Lashen, A. L.
    Toss, M. T.
    Green, A. G.
    Mongan, N. M.
    Rakha, E. R.
    JOURNAL OF PATHOLOGY, 2023, 261 : S10 - S10
  • [25] Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer
    Luca Gianni
    Marco Colleoni
    Giancarlo Bisagni
    Mauro Mansutti
    Claudio Zamagni
    Lucia Del Mastro
    Stefania Zambelli
    Giampaolo Bianchini
    Antonio Frassoldati
    Ilaria Maffeis
    Pinuccia Valagussa
    Giuseppe Viale
    npj Breast Cancer, 8
  • [26] The Correlation of Nottingham Prognostic Index with Immunoexpression of ER, PR, HER2, and Ki67 in Breast Cancer Tissue
    Ruangpratheep, Chetana
    Piyaisrakul, Supakorn
    ANNALS OF ONCOLOGY, 2019, 30 : 93 - 93
  • [27] Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer
    Gianni, Luca
    Colleoni, Marco
    Bisagni, Giancarlo
    Mansutti, Mauro
    Zamagni, Claudio
    Del Mastro, Lucia
    Zambelli, Stefania
    Bianchini, Giampaolo
    Frassoldati, Antonio
    Maffeis, Ilaria
    Valagussa, Pinuccia
    Viale, Giuseppe
    NPJ BREAST CANCER, 2022, 8 (01)
  • [28] Evaluation of ER, PgR, HER2 and Ki67 as predictors of response to neoadjuvant chemotherapy for operable breast cancer
    Burcombe, RJ
    Makris, A
    Richman, PI
    Pittam, M
    Daley, F
    Nobe, S
    Wilson, GD
    BRITISH JOURNAL OF CANCER, 2001, 85 : 50 - 50
  • [29] Accelerated glycolysis in tumor microenvironment is associated with worse survival in triple-negative but not consistently with ER+/HER2-breast cancer
    Oshi, Masanori
    Roy, Arya Mariam
    Yan, Li
    Sasamoto, Mahato
    Tokumaru, Yoshihisa
    Wu, Rongrong
    Yamada, Akimitsu
    Yamamoto, Shinya
    Chishima, Takashi
    Narui, Kazutaka
    Endo, Itaru
    Takabe, Kazuaki
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (07): : 3041 - +
  • [30] Prognostic significance of Ki67 in Chinese women diagnosed with ER+/HER2- breast cancers by the 2015 St. Gallen consensus classification
    Hu, Yue
    Gu, Ran
    Zhao, Jinghua
    Yang, Yaping
    Liu, Fengtao
    Jin, Liang
    Chen, Kai
    Jia, Haixia
    Wang, Hongli
    Liu, Qiang
    Su, Fengxi
    Jia, Weijuan
    BMC CANCER, 2017, 17
12345